These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 23529188)
21. Using apoptosis for targeted cancer therapy by a new gonadotropin releasing hormone-DNA fragmentation factor 40 chimeric protein. Ben-Yehudah A; Aqeilan R; Robashkevich D; Lorberboum-Galski H Clin Cancer Res; 2003 Mar; 9(3):1179-90. PubMed ID: 12631624 [TBL] [Abstract][Full Text] [Related]
22. GM-CSF binding to its receptor induces oligomerisation of the common beta-subunit. McClure BJ; Woodcock JM; Harrison-Findik D; Lopez AF; D'Andrea RJ Cytokine; 2001 Feb; 13(4):240-3. PubMed ID: 11237432 [TBL] [Abstract][Full Text] [Related]
23. Comparison of in vivo and in vitro effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients with acute myeloid leukemia. Estrov Z; Estey EH; Andreeff M; Talpaz M; Kurzrock R; Reading CL; Deisseroth AB; Gutterman JU Exp Hematol; 1992 Jun; 20(5):558-64. PubMed ID: 1587302 [TBL] [Abstract][Full Text] [Related]
24. Signal transduction of steel factor and granulocyte-macrophage colony-stimulating factor: differential regulation of transcription factor and G1 cyclin gene expression, and of proliferation in the human factor-dependent cell line MO7. Hallek M; Ando K; Eder M; Slattery K; Ajchenbaum-Cymbalista F; Griffin JD Leukemia; 1994 May; 8(5):740-8. PubMed ID: 7514243 [TBL] [Abstract][Full Text] [Related]
25. Functional interactions between colony-stimulating factors and the insulin family hormones for human myeloid leukemic cells. Oksenberg D; Dieckmann BS; Greenberg PL Cancer Res; 1990 Oct; 50(20):6471-7. PubMed ID: 1698537 [TBL] [Abstract][Full Text] [Related]
27. Nup98-HoxA9 immortalizes myeloid progenitors, enforces expression of Hoxa9, Hoxa7 and Meis1, and alters cytokine-specific responses in a manner similar to that induced by retroviral co-expression of Hoxa9 and Meis1. Calvo KR; Sykes DB; Pasillas MP; Kamps MP Oncogene; 2002 Jun; 21(27):4247-56. PubMed ID: 12082612 [TBL] [Abstract][Full Text] [Related]
28. Effects of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor on lung cancer: roles of cyclooxygenase-2. Uemura Y; Kobayashi M; Nakata H; Kubota T; Saito T; Bandobashi K; Taguchi H Oncol Rep; 2007 Apr; 17(4):955-61. PubMed ID: 17342342 [TBL] [Abstract][Full Text] [Related]
29. A recombinant GM-CSF-PE40 ligand toxin is functionally active but not cytotoxic to cells. O'Brien P; Smythe A; Biggs JC; Smith GM Immunol Cell Biol; 1997 Jun; 75(3):289-94. PubMed ID: 9243295 [TBL] [Abstract][Full Text] [Related]
30. Selective cytotoxicity of recombinant STXA1-GM-CSF protein in hematopoetic cancer cells. Roudkenar MH; Jafari A; Oloomi M; Bouzari S Cell Biol Toxicol; 2006 May; 22(3):213-9. PubMed ID: 16598407 [TBL] [Abstract][Full Text] [Related]
31. Enhanced chemosensitivity of clonogenic blasts from patients with acute myeloid leukemia by G-CSF, IL-3 or GM-CSF stimulation. te Boekhorst PA; Löwenberg B; Vlastuin M; Sonneveld P Leukemia; 1993 Aug; 7(8):1191-8. PubMed ID: 7688839 [TBL] [Abstract][Full Text] [Related]
32. Discovery and characterization of a novel splice variant of the GM-CSF receptor alpha subunit. Pelley JL; Nicholls CD; Beattie TL; Brown CB Exp Hematol; 2007 Oct; 35(10):1483-94. PubMed ID: 17681666 [TBL] [Abstract][Full Text] [Related]
33. Sensitization of breast cancer cells to doxorubicin via stable cell line generation and overexpression of DFF40. Bagheri F; Safarian S; Eslaminejad MB; Sheibani N Biochem Cell Biol; 2015 Dec; 93(6):604-10. PubMed ID: 26529233 [TBL] [Abstract][Full Text] [Related]
34. Comparison of four methods for the purification and refolding of human interleukin-2-mouse granulocyte/macrophage colony-stimulating factor fusion protein. Wen Q; Ma L; Luo W; Zhou MQ; He D; Lin Y; Wu ZQ; He XW; Wang JF; Wang XN Biotechnol Appl Biochem; 2008 May; 50(Pt 1):41-8. PubMed ID: 17708750 [TBL] [Abstract][Full Text] [Related]
35. [GM-CSF regulates the Vp16 induced leukemic cell apoptosis]. Li X; Li C; Zou P; Chen Q; Chen Y; Wang B; Zhang Z; Hou Y Zhonghua Xue Ye Xue Za Zhi; 1997 Jun; 18(6):299-301. PubMed ID: 15622623 [TBL] [Abstract][Full Text] [Related]
36. DFF40-iRGD, a novel chimeric protein with efficient cytotoxic and apoptotic effects against triple-negative breast cancer cells. Amrollahi-Nia R; Akbari V; Shafiee F Biotechnol Lett; 2021 Oct; 43(10):1967-1976. PubMed ID: 34482510 [TBL] [Abstract][Full Text] [Related]
37. MDM2 protein overexpression inhibits apoptosis of TF-1 granulocyte-macrophage colony-stimulating factor-dependent acute myeloblastic leukemia cells. Urashima M; Teoh G; Chauhan D; Ogata A; Shirahama S; Kaihara C; Matsuzaki M; Matsushima H; Akiyama M; Yuza Y; Maekawa K; Anderson KC Blood; 1998 Aug; 92(3):959-67. PubMed ID: 9680365 [TBL] [Abstract][Full Text] [Related]
38. DT388-GM-CSF, a novel fusion toxin consisting of a truncated diphtheria toxin fused to human granulocyte-macrophage colony-stimulating factor, prolongs host survival in a SCID mouse model of acute myeloid leukemia. Hall PD; Willingham MC; Kreitman RJ; Frankel AE Leukemia; 1999 Apr; 13(4):629-33. PubMed ID: 10214872 [TBL] [Abstract][Full Text] [Related]